Literature DB >> 2904800

Virulence factors of Bordetella pertussis.

F R Mooi1.   

Abstract

Clearly, B. pertussis has evolved very elaborate mechanisms to maintain itself in the human host. Three different proteins (FHA, pertussis toxin and fimbriae) have been implicated in adherence. Furthermore, a number of toxins are produced (pertussis toxin, adenylate cyclase, dermonecrotic toxin, and tracheal cytotoxin) which destroy the clearance mechanisms of the respiratory tract, or suppress the immune response. There is evidence that B. pertussis may survive intracellularly, and the possibility that it is a facultative intracellular parasite should certainly be explored. The availability of a large number of cloned virulence genes, and a system to construct well defined mutants by allelic exchange (Stibbitz et al. 1986) will greatly facilitate the study of Bordetella virulence factors at the molecular level. It opens the possibility to construct avirulent strains, which are still able to colonize and stimulate the local immune response. Such strains may be used as live, oral vaccines, to present (heterologous) antigens to the mucosal immune system of the respiratory tract.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2904800     DOI: 10.1007/BF00461865

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


  48 in total

1.  Antigenic modulation of Bordetella pertussis.

Authors:  B W LACEY
Journal:  J Hyg (Lond)       Date:  1960-03

2.  Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes.

Authors:  B Aricò; R Rappuoli
Journal:  J Bacteriol       Date:  1987-06       Impact factor: 3.490

3.  Whooping cough is first described as a disease sui generis by Baillou in 1640.

Authors:  T C Cone
Journal:  Pediatrics       Date:  1970-10       Impact factor: 7.124

4.  Antigenic relationship between serotype-specific agglutinogen and fimbriae of Bordetella pertussis.

Authors:  L A Ashworth; L I Irons; A B Dowsett
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

5.  Filamentous hemagglutinin and pertussis toxin promote adherence of Bordetella pertussis to cilia.

Authors:  E Tuomanen; A Weiss; R Rich; F Zak; O Zak
Journal:  Dev Biol Stand       Date:  1985

Review 6.  Islet-activating protein, pertussis toxin: a specific uncoupler of receptor-mediated inhibition of adenylate cyclase.

Authors:  M Ui; T Katada; T Murayama; H Kurose; M Yajima; M Tamura; T Nakamura; K Nogimori
Journal:  Adv Cyclic Nucleotide Protein Phosphorylation Res       Date:  1984

7.  Separation and purification of the hemagglutinins from Bordetella pertussis.

Authors:  Y Sato; J L Cowell; H Sato; D G Burstyn; C R Manclark
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

8.  Genetic diversity and relationships in populations of Bordetella spp.

Authors:  J M Musser; E L Hewlett; M S Peppler; R K Selander
Journal:  J Bacteriol       Date:  1986-04       Impact factor: 3.490

9.  ADP-ribosyltransferase activity of pertussis toxin and immunomodulation by Bordetella pertussis.

Authors:  W J Black; J J Munoz; M G Peacock; P A Schad; J L Cowell; J J Burchall; M Lim; A Kent; L Steinman; S Falkow
Journal:  Science       Date:  1988-04-29       Impact factor: 47.728

10.  Structure-function relationship of islet-activating protein, pertussis toxin: biological activities of hybrid toxins reconstituted from native and methylated subunits.

Authors:  K Nogimori; M Tamura; M Yajima; N Hashimura; S Ishii; M Ui
Journal:  Biochemistry       Date:  1986-03-25       Impact factor: 3.162

View more
  10 in total

1.  A vir-repressed gene of Bordetella pertussis is required for virulence.

Authors:  D T Beattie; R Shahin; J J Mekalanos
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

2.  Characterization of the bvgR locus of Bordetella pertussis.

Authors:  T J Merkel; C Barros; S Stibitz
Journal:  J Bacteriol       Date:  1998-04       Impact factor: 3.490

Review 3.  An overview of the status of acellular pertussis vaccines in practice.

Authors:  A L Lopez; D A Blumberg
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

4.  Identification of a locus required for the regulation of bvg-repressed genes in Bordetella pertussis.

Authors:  T J Merkel; S Stibitz
Journal:  J Bacteriol       Date:  1995-05       Impact factor: 3.490

5.  Repressor binding to a regulatory site in the DNA coding sequence is sufficient to confer transcriptional regulation of the vir-repressed genes (vrg genes) in Bordetella pertussis.

Authors:  D T Beattie; M J Mahan; J J Mekalanos
Journal:  J Bacteriol       Date:  1993-01       Impact factor: 3.490

6.  Contribution of regulation by the bvg locus to respiratory infection of mice by Bordetella pertussis.

Authors:  T J Merkel; S Stibitz; J M Keith; M Leef; R Shahin
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  A phase variant of Bordetella pertussis with a mutation in a new locus involved in the regulation of pertussis toxin and adenylate cyclase toxin expression.

Authors:  N H Carbonetti; N Khelef; N Guiso; R Gross
Journal:  J Bacteriol       Date:  1993-10       Impact factor: 3.490

8.  Global regulatory mechanisms affect virulence gene expression in Bordetella pertussis.

Authors:  H Graeff-Wohlleben; H Deppisch; R Gross
Journal:  Mol Gen Genet       Date:  1995-04-10

9.  Fimbrial phase variation in Bordetella pertussis: a novel mechanism for transcriptional regulation.

Authors:  R Willems; A Paul; H G van der Heide; A R ter Avest; F R Mooi
Journal:  EMBO J       Date:  1990-09       Impact factor: 11.598

10.  Co-detection of Bordetella pertussis and other respiratory organisms in children hospitalised with lower respiratory tract infection.

Authors:  Rudzani Muloiwa; Felix S Dube; Mark P Nicol; Gregory D Hussey; Heather J Zar
Journal:  Sci Rep       Date:  2020-10-02       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.